Sichuan Kelun Pharmaceutical

Company snapshot

Sichuan Kelun Pharma is a pharmaceuticals company based out of CHENGDU, SIC, China.

• 4 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Sichuan Kelun Pharmaceutical. Not investment advice.

• What is Sichuan Kelun Pharmaceutical?

  Sichuan Provincial People's is a pharma organization headquartered in CN. Primary therapeutic focus areas include Sepsis, Tumor, Solid, Carcinoma, Non-Small-Cell Lung, Advanced Solid Tumors. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s), and 0 patent record(s) to

• Is Sichuan Kelun Pharmaceutical publicly traded?

  Sichuan Kelun Pharmaceutical appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Sichuan Kelun Pharmaceutical develop or market?

  We link 6 drug profile(s) where Sichuan Kelun Pharmaceutical is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/sichuan-provincial-people-s-hospital#company-drugs.

• What are the latest developments for Sichuan Kelun Pharmaceutical?

  In the last 12 months our linked public records show 4 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Sichuan Kelun Pharmaceutical focus on?

  Sichuan Kelun Pharmaceutical focuses on Sepsis, Tumor, Solid, Carcinoma, Non-Small-Cell Lung based on our analysis of their pipeline programs and drug development activities.